Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.19.3
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Sales $ 231,231 $ 439,982 $ 940,459 $ 2,114,297
Cost of sales (317,602) (305,747) (947,710) (1,267,592)
Gross profit (86,371) 134,235 (7,251) 846,705
Operating Expenses        
Selling and marketing 100,066 52,926 336,873 210,729
General and administrative 1,410,509 1,277,783 4,339,943 5,268,174
Depreciation and amortization 39,211 44,473 151,370 133,891
Total operating expenses 1,549,786 1,375,182 4,828,186 5,612,794
Loss from Operations (1,636,157) (1,240,947) (4,835,437) (4,766,089)
Other (Income) Expense        
Interest expense, net 29,140 92,972 256,169 499,719
Other income (165,508) (165,508)
Gains from foreign currency transactions (74,179) (58,579) (106,513) (58,579)
Total other (income) expense (210,547) 34,393 (15,852) 441,140
Net Loss (1,425,610) (1,275,340) (4,819,585) (5,207,229)
Net loss attributable to non-controlling interest 109,106 155,515
Series B preferred stock dividends (181,746) (225,998) (539,311) (539,311)
Net Loss Attributable to Common Stockholders $ (1,498,250) $ (1,501,338) $ (5,203,381) $ (5,746,540)
Net Loss per Common Share $ (0.03) $ (0.03) $ (0.10) $ (0.13)
Weighted Average Number of Common Shares Outstanding:        
Basic and Diluted 57,933,937 46,159,288 52,782,987 44,223,334